A major Swedish study links maternal TORCH infections during pregnancy to a significantly higher risk of autism and intellectual disability in children.

A Swedish study of 3.7 million people found that rare TORCH infections passed from pregnant women to fetuses significantly elevate the risk of autism and intellectual disability.

Researchers tracked health outcomes across decades, establishing that congenital exposure to the group of pathogens—which includes toxoplasmosis, rubella, cytomegalovirus, and herpes simplex—substantially increases long-term neurodevelopmental complications in children.

Separately, clinical data indicates that cardiovascular protections conferred by GLP-1 receptor agonists fade rapidly after treatment stops. Patients who discontinued medications including Ozempic, Wegovy, Mounjaro, or Zepbound faced a 22 percent higher risk of heart attack, stroke, and death over two years compared to patients who maintained continuous therapy.

Oceanic and climate warning signs

In environmental science, observational data confirmed that a critical section of the Atlantic Meridional Overturning Circulation has been weakening across a broad stretch of ocean for nearly two decades. The shift coincides with severe regional water supply disruptions, as Lake Powell and Lake Mead dropped to their lowest levels on record following an extraordinarily dry winter in the Colorado River Basin.

Farther north, satellite monitoring showed the Arctic sea ice melt season now lasts roughly 40 days longer than in 1979, despite rapid ice expansion unexpectedly leveling off around 2010 due to changing cloud coverage and decreasing ice thickness.

Deep space instrument activations

Astronomers achieved a operational milestone in space exploration after NASA successfully activated the 300-megapixel infrared camera on the Roman Space Telescope. Operating one million miles from Earth, the observatory began testing its planet-hunting coronagraph ahead of full science operations aimed at mapping dark matter and exoplanets.

Cancer therapeutics and neural recovery

Medical researchers identified new pathways to overcome drug resistance in oncology. An experimental compound designated CS18 restored drug sensitivity in resistant lung cancer cells by disabling multiple defense mechanisms that tumors use to survive standard treatments.

In neurological research, investigations demonstrated that long COVID can damage dopamine-releasing brain neurons, providing a mechanical explanation for persistent post-viral fatigue, slowed movement, and cognitive impairment. Clinical evaluations for both the experimental oncology treatments and target neural therapies remain ongoing.